The SWI/SNF chromatin remodeling complex subunit BAF53B as an immunohistochemical marker for neuroendocrine neoplasms
Authors:
- 14 September 2025
- journal article
- research article
- Published by Springer Nature in Human Cell
- Vol. 38 (6) , 1-8
Abstract
The Switch/Sucrose Nonfermentable (SWI/SNF) complexes are chromatin remodeling factors that consist of multiple protein subunits. Each subunit plays a distinct role in gene regulation and is aberrantly expressed in tumors, such as neuroendocrine neoplasms (NENs). BRG1-associated factor 53B (BAF53B), which is also known as ACTL6B, is a neuron-specific subunit that acts as a regulator during neurogenesis. Because the BAF53B expression pattern in tumors is unknown, the present study investigated the expression in cell lines and tissues. Publicly available transcriptome data indicated that BAF53B mRNA was highly expressed in NEN-derived cell lines. We performed immunohistochemical staining on tissue microarrays of different types of NENs with neuroendocrine (NE) marker expression (n = 117) (small cell lung carcinoma (SCLC)lung carcinoid (LC), gastroenteropancreatic-NEN (GEP-NEN), esophageal neuroendocrine carcinoma (ENEC), medullary thyroid carcinoma (MTC), neuroblastoma (NB), and pheochromocytoma (PHEO)) and non-NENs (n = 178). While few positive cells were observed in many cases of non-NENs (e.g., lung adenocarcinoma), positive expression was found in cases of NENs (SCLC (14/19, 73.7%), LC (12/16, 75.0%), GEP-NEN (4/9, 44.4%), ENEC (1/2, 50.0%), MTC (24/27, 88.9%), NB (18/20, 90.0%), and PHEO (16/24, 66.7%)). In NCI-H889 cells, BAF53B knockdown did not affect the cellular viability, and its effect on NE marker expression was only marginal. However, a gene expression microarray analysis suggested that BAF53B-regulated genes were associated with the development and progression of NENs. Our analysis revealed that BAF53B was an immunohistochemical marker for specific NENs, indicating its potentially important role in the pathogenesis.Keywords
Funding Information
- Japan Society for the Promotion of Science (18K09545, 24K12892)
This publication has 45 references indexed in Scilit:
- ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancersProceedings of the National Academy of Sciences, 2014
- Neuron-specific chromatin remodeling: A missing link in epigenetic mechanisms underlying synaptic plasticity, memory, and intellectual disability disordersNeuropharmacology, 2014
- SWI/SNF Chromatin-remodeling Factors: Multiscale Analyses and Diverse FunctionsJournal of Biological Chemistry, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- MicroRNA-mediated conversion of human fibroblasts to neuronsNature, 2011
- MicroRNAs miR-199a-5p and -3p Target the Brm Subunit of SWI/SNF to Generate a Double-Negative Feedback Loop in a Variety of Human CancersCancer Research, 2011
- MicroRNA-mediated switching of chromatin-remodelling complexes in neural developmentNature, 2009
- Regulation of Dendritic Development by Neuron-Specific Chromatin Remodeling ComplexesNeuron, 2007
- Identification of a polymorphic, neuron-specific chromatin remodeling complexGenes & Development, 2002
- Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinomaOncogene, 2001